Singapore markets closed

IDEAYA Biosciences, Inc. (30J.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
36.000.00 (0.00%)
At close: 08:06AM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

Currency in USD. All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
157,018
68,632
92,046
72,037
-
Other short-term investments
368,096
296,197
154,724
211,548
-
Total cash
525,114
364,829
246,770
283,585
-
Net receivables
18
211
1,103
1,877
-
Other current assets
7,500
5,414
3,123
3,143
-
Total current assets
532,632
370,454
250,996
288,605
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
18,021
16,546
14,258
13,370
-
Accumulated depreciation
-9,611
-7,553
-5,597
-3,894
-
Net property, plant and equipment
8,410
8,993
8,661
9,476
-
Equity and other investments
107,492
8,317
121,293
0
-
Other long-term assets
782
205
397
188
-
Total non-current assets
116,684
17,515
130,351
9,664
-
Total assets
649,316
387,969
381,347
298,269
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
6,598
4,280
2,100
953
-
Accrued liabilities
18,756
16,999
12,320
8,516
-
Deferred revenues
0
8,568
29,040
27,613
-
Other current liabilities
-
-
-
18
63
Total current liabilities
27,101
31,718
45,159
38,640
-
Non-current liabilities
Deferred revenues
0
5,185
31,192
56,160
-
Other long-term liabilities
-
-
-
12
34
Total non-current liabilities
1,125
6,796
34,674
61,355
-
Total liabilities
28,226
38,514
79,833
99,995
-
Stockholders' equity
Common stock
7
5
4
3
-
Retained earnings
-348,364
-235,403
-176,748
-126,986
-
Accumulated other comprehensive income
562
-2,871
-712
7
-
Total stockholders' equity
621,090
349,455
301,514
198,274
-
Total liabilities and stockholders' equity
649,316
387,969
381,347
298,269
-